June 17, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Direct-to-consumer pharmacies could offer substantial savings for patients taking generic medications, according to experts. John Lin, MD, MSHP, assistant professor of Health Services Research at The University of Texas MD Anderson Cancer Center, and colleagues recently published a research letter in Annals of Internal Medicine evaluating savings from direct-to-consumer (DTC) pharmacy
June 17, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Why one health system invested in its PBM as GLP-1 costs surged

Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims data

Tanner Health and InStockRx Partner to Ensure Every Medication Dose Reaches a Patient in Need

How lab data powers precision commercialization to drive therapy adoption

The rise of direct-to-consumer channels, driven largely by consumer willingness to pay for GLP-1s for weight loss without using…

The case for direct-to-patient (DTP) has been clearly made. | The case for DTP is made. What separates programs that deliver from…

Patients could save more buying non-branded copycat drugs, even if they don't have insurance.

In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Susan Cornell, PharmD, CDCES, FAPhA,…

Can clinical guardrails survive the direct-to-consumer software playbook pharma has now adopted?

Compounded medications currently represent an estimated 1% to 3% of all prescriptions written in the United States, according to…